ワシントンにおける潰瘍性大腸炎の臨床試験
ワシントン内の拠点で、潰瘍性大腸炎に関する22件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Washington Gastroenterology - Bellevue /ID# 283966, Bellevue
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
- The Vancouver Clinic /ID# 280497, Vancouver
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- GI Alliance, Bellevue
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of Washington School Medicine, Seattle
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 004, Seattle
- Site 019, Tacoma
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-021, Bellevue
- Site US-029, Tacoma
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance Tacoma, Tacoma
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Seattle Children's Hospital, Seattle
- MultiCare Health System, Tacoma
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington Gastroenterology - Tacoma, Tacoma
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Washington Gastroenterology - Bellevue, Bellevue
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Swedish Medical Center, Seattle
- Principle Research Solutions, Spokane
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
- 他1件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Washington Gastroenterology- GIA, Tacoma
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- The Vancouver Clinic Inc. P.S. - Site Number: 8400090, Vancouver
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
被験者募集中第3相
全年齢 · 全性別 · 2026/09/09更新 · NCT06651281A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance Tacoma, Tacoma
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577856Familial Inflammatory Bowel Disease Early Risk
- Seattle Children's Hospital, Seattle
被験者募集中観察研究健康なボランティア歓迎
0歳〜55歳 · 全性別 · 2026/08/28更新 · NCT07791862A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- University of Washington, Seattle
- Digestive Health Specialists, Tacoma
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/21更新 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Bellevue - Site Number: 8400143, Bellevue
- The Vancouver Clinic Inc. P.S. - Site Number: 8400090, Vancouver
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- MultiCare Institute for Research & Innovation, Tacoma
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/03更新 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Washington Gastroenterology, Tacoma
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Multicare Health System Institute for Research and Innovation, Tacoma
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Seattle Children's Hospital, Seattle
被験者募集中観察研究
6歳〜21歳 · 全性別 · 2026/04/24更新 · NCT06315179A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bellevue
- Mirador Therapeutics Selected Site, Silverdale
- Mirador Therapeutics Selected Site, Tacoma
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。